Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose - Contrera, J F; Matthews, E J; Kruhlak, N L; Benz, R D (Regul Toxicol Pharmacol, 2004)